Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Long-Term Investments: 2020-2022

Historic Long-Term Investments for Oncology Institute (TOI) over the last 2 years, with FY2022 value amounting to $58.4 million.

  • Oncology Institute's Long-Term Investments changed N/A to $58.9 million in Q2 2023 from the same period last year, while for Jun 2023 it was $58.9 million, marking a year-over-year change of. This contributed to the annual value of $58.4 million for FY2022, which is N/A changed from last year.
  • Oncology Institute's Long-Term Investments amounted to $58.4 million in FY2022.
  • Oncology Institute's 5-year Long-Term Investments high stood at $230.3 million for FY2020, and its period low was $58.4 million during FY2022.